Activation of the complement system during immunotherapy with recombinant Interleukin-2: Relation to the development of side effects - Thijs, L G; Hack, C E; Strack van Schijndel, R JM; Nuijens, J H; Wolbink, G J; Eerenberg-Belmer, A JM; van der Vail, H; Wagstaff, J (J Immunol, 1990)